Results for the company's Cepheus phase 3 trial showed a 60.9% improvement in eliminating cancer cells and a 43% reduction in the cancer progressing or causing death when its treatmentis used in ...
The drug BMF-219 works by increasing, preserving and reactivating patients’ own healthy insulin-producing cells. Read more at ...
In this opinion piece, Richard Owen of the American Peanut Council argues for negotiating new trade deals and ...
A groundbreaking new drug to treat schizophrenia called Cobenfy, owned by pharmaceutical firm Bristol Myers Squibb, has been ...
In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...
Stocks traded mixed Friday after the Federal Reserve’s preferred inflation measure, the personal consumption expenditures ...
Even after a hurricane’s immediate flooding threat goes away, residents could face a host of potential health problems from the water — and what it leaves behind.
Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.
The increase is nearly double last year’s 7.7. percent raise and driven by higher market costs this year, the Office of ...
The Food Safety and Drug Administration Department on Friday collected samples of ‘elaichi daana’ or cardamom seeds being distributed as ‘prasad’ at the Ram Janmabhoomi temple here and sent them for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback